Hemoglobin A1c (HbA1c) should be used to diagnose diabetes and prediabetes, according to new recommendations from the American Diabetes Association (ADA).
Under the new recommendations, HbA1c levels of 5.7% to 6.4% would indicate prediabetes and 6.5% or higher would indicate diabetes, according to a report in Diabetes Care (2010;33[Suppl 1]:s1-s99). Unlike fasting plasma glucose and oral glucose tolerance testing, the HbA1c test does not require overnight fasting.
The ADA hopes that adding the option of this simple blood test to the diagnostic arsenal for diabetes will encourage more people to be screened, ultimately reducing the rate of kidney disease and other complications of diabetes.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.